Detalhe da pesquisa
1.
The COVID-19 impact on severe uncontrolled asthma costs and biologic use.
Allergy Asthma Proc
; 44(5): 340-344, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37641228
2.
Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.
Allergy Asthma Proc
; 43(5): 383-387, 2022 09 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35760498